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Abstract
Background: Young people’s compliance with carriage of adrenaline auto-injectors (AAI) may be as low as 41%,
yet we lack research exploring their preferences regarding these devices.
Objective: This qualitative study explored young people’s ideas about AAI design and features which may
facilitate their carriage and use.
Methods: Young people aged 13-18 years prescribed an AAI for severe allergic reaction were invited to
participate in in-depth, semi-structured, face-to-face interviews about AAI design. Interviews were recorded,
transcribed verbatim and analyzed using thematic content analysis.
Results: From 23 interviews, seven major themes were identified: accessibility and carriage, comprehensibility of
instructions, indication of correct administration, safety, speed of administration, visibility and identification and
precise drug delivery. Young people made several suggestions for how AAIs may be adapted to improve carriage,
including reduced size to enable pocket-carriage. Comprehensibility was thought to be enhanced by the use of
pictographic instructions and audio-prompts to encourage prompt and accurate administration. Needle guards were
seen as beneficial to reduce needle phobia, prevent accidental injury and provide reassurance that the device had
been administered. Young people were conflicted between wanting a device which enabled discreet carriage, versus
an AAI which was bold and clearly identifiable as a medical device in case of emergency.
Conclusion: This study identified key AAI features important to young people, together with design issues
deterring day-to-day carriage of AAIs and their emergency, time-pressured usage. We demonstrated considerable
scope for AAI design modifications to improve young peoples’ perception of devices and facilitate their carriage and
use.
Keywords: Young people; Adolescents; Teenagers; Adrenaline auto-
injector; Design; Preference
Abbreviations: AAI: Adrenaline Auto-injectors
Introduction
Due to the fast onset and potentially fatal nature of anaphylaxis,
intramuscular adrenaline is the recommended first-line treatment for
anaphylaxis [1-5], and early administration is imperative. Numerous
adrenaline auto-injectors (AAIs) have been designed so that the
immediate self-administration of adrenaline is possible. The risks of
accidental, unintentional exposure to allergens and the speed of onset
of anaphylaxis require patients to always carry their AAI.
Young people have the highest risk of severe and fatal anaphylactic
reactions, with most fatalities being a result of delayed or non-
administration of adrenaline [6-9]. It has been consistently
documented that young people’s compliance with the carriage and use
of AAIs is poor [10-12]. A recent study estimated that 59% of young
people do not carry their AAIs at all times [13]. Even when carried and
available for use, 75%-83% of teenagers or the parents of younger
children did not use the AAI when needed [14,15]. Despite an
apparent reluctance to carry and use AAIs, there has been little
exploration of the young peoples’ perspective and their ideas for AAI
design. We therefore wished to explore young people’s views of AAIs,
asking them to describe the characteristics that they most value, and
what they would wish to be incorporated in future AAI design,
particularly focusing on those that would facilitate carriage and use.
Methods
A qualitative design was selected to enable in-depth exploration of
young people’s views of AAIs.
Recruitment
Participants were recruited from outpatient clinics and from general
practices in the South East of England. Participants were eligible for
inclusion if they were aged 13-18 years, with a prescription of an AAI
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for food or venom allergy indicating a severity of reaction which
warrants medication. Eligible participants and their guardians were
sent a letter of invitation and information leaflet (participant and
parental). Consent was obtained for participants aged 16 years or over.
For participants aged 13-15 years assent was obtained together with
consent from their parents. Recruitment of participants continued
until data saturation was achieved, that is no new information was
generated from three consecutive interviews.
Interviews
Face-to-face interviews, were conducted by one of three researchers
(LB, MD or CB), all trained in qualitative interview techniques, in a
setting of the participants’ choosing (their general practice surgery, the
local Medical School or Hospital). A semi-structured interview guide
facilitated coverage of all aspects of design whilst allowing participants
to discuss issues of importance to them. Nine different AAI models
(current, discontinued and prototypes including Anapen, Auvi-Q,
Emerade EpiPen (previous and next generation models), Jext, Oval
(two prototypes) and Twinject) were available to stimulate discussion.
Interviews were recorded, transcribed verbatim and anonymised.
Data analysis
Data were analyzed using Bernard’s structured method of thematic
content analysis [16]. Transcripts were analyzed independently by
three researchers (LL, CB and CJ) to generate potential themes. The
preliminary analysis was then discussed with the research team and a
framework agreed for analysis.
Ethical approval for the study was obtained by the National Institute
for Social Care and Health Research RES Committee, Wrexham, REC
reference 12/WA/0061.
Results
Twenty three interviews of 30-60 min duration were conducted.
Participants ranged from 13 to 17 years of age, 74% were female and
17% had experience of using their AAI (Table 1). Seven major themes
were identified each relating to a design feature; accessibility and
carriage, comprehensibility of instructions, indication that device had
been correctly administered, safety, speed of administration, visibility
and identification and precise drug delivery (Table 2).
Gender Age Allergen Current AAI AAI
M 13 Peanuts, seeds EpiPen No
F 14 Eggs, nuts, seeds EpiPen No
F 15 Fish, strawberries EpiPen Yes
F 14 Latex Jext No
F 13 Nuts EpiPen No
F 14 Nuts EpiPen No
F 13 Nuts, seeds EpiPen No
F 13 Nuts Jext Yes
F 16 Peanuts, legumes Jext No
F 15 Peanuts EpiPen No
M 13 Unknown EpiPen No
F 14 Nuts EpiPen No
F 17 Nuts, seeds EpiPen Yes
F 17 Peanuts, legumes Jext No
M 14 Nuts Jext No
M 14 Nuts EpiPen No
M 14 Peanuts Jext No
F 14 Nuts Jext No
F 14 Nuts, fish EpiPen No
F 15 Apples, pears, nuts EpiPen No
F 17 Nuts EpiPen No
F 16 Peanuts, shellfish, seeds,
kiwi, latex
Jext Yes
M 16 Legumes EpiPen No
Table 1: Demographics
Carriage and accessibility Reduced size to enable easier carriage
Facility to attach AAI to bag or self
Comprehensibility of instructions Added value of pictures
Needed as a reminder of how to administer
Clear, simple instructions to enable self and bystander use
Benefit of colour coding
Reduced quantity of text
Clear labelling of ends of device
Requirement for instructions to be printed on device
Requirement for text and pictorial instructions
Indication of correct administration Audio confirmation
Needle guard as visual confirmation
Window to show medication has been used
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Ever used
Safety features Protective casing
Appeal of needle guard/safety cap
Speed of administration Simplicity of device (i.e. number of caps/steps)
Reduced intramuscular needle time
Visibility and identification Bright colours to ensure visibility
Device to resemble medication and be familiar
Device to be discreet and not wishing to stand out from the crowd
Precise drug delivery Ergonomic considerations (i.e. grip)
Injecting mechanism
Additional features Multiple doses in once device
Table 2: Major themes and subthemes identified
Accessibility and carriage
All participants discussed the need to modify the size of AAIs to
make carriage easier. The majority of participants wanted the device to
be smaller to enable pocket carriage, often citing the longer length
devices as impractical: "Pocket size-so smaller. Thinner so it doesn't
take up so much room. And just easier and more mobile" (Male aged
13). "If you've got it in your pocket then you can just take it out and use
it. So it's quite easier if you're having an allergic reaction" (Male aged
13).
Discussion of reduced size was often linked with improved
adherence: "Sometimes I leave the house knowing I don't have it
(AAI). I think "oh am just popping here and I will be fine." But it is
because it is big, like if it was small I would just always have it in my
pocket. Like my key-I always have it in my pocket. So if it was smaller I
think it would just be a normal thing to have it on me" (Female aged
16). "I would carry it more if it fit it in my pocket" (Male aged 16).
However, a smaller device was recognized to be not without its own
problems, particularly that if too small it might get lost. Participants
suggested two possible design features to rectify this:
A choice of sizes for different occasions: "It would probably be a
good idea to offer people small ones and larger ones, so that they could
take them to different places and they have that flexibility" (Female
aged 17).
Integrating into the AAI design a mechanism to secure the device to
self, clothes or bag: “You could sort of clip it to your bag, so it doesn't
fall right to the bottom. And then, when you need it you can find it, so
I would say that is helpful" (Female aged 13).
The comments about improving portability were moderated by
concern that any significant change in design or dimensions may
reduce bystanders’ recognition of the device. The participant quoted
above went on to say “a lot of people aren't really familiar with it (an
AAI) and also, if you are changing the shape or size of it slightly then
people will be even less familiar".
Comprehensibility of instructions
Clear and simple instructions were required at two levels, for young
person themselves and for a bystander assisting in an emergency.
Young people placed great value on having pictographic instructions
which were seen to aid speed of familiarization, but also made the
instructions universally accessible, as they were independent of reading
ability or linguistic skills:
"Because if people can't read then pictures tell you what to do"
(Female aged 15).
"I think pictures are sometimes better for something like this…
Because if you don’t really have ... again if you don’t have time to… to
read through all of it" (Female aged 17).
They expressed a strong preference for integration of instructions on
the device, “Printed (instructions) on the side of the pen so that you
know where it is" (Female aged 13).
One of the devices available to participants to prompt discussion
included an audio prompt AAI (Auvi-Q®). The audio-prompt was
perceived as a favorable design feature, not just because “not everyone
will understand the writing" (Female aged 14), but because listening
requires less concentration “It is much easier than reading it. Especially
if I am injecting myself I might (be) so panicked that I can't really read
instructions" (Female aged 13).
To maximize benefit from an audio-prompt, young people wanted a
voice that was ‘human’, ‘normal’: "I think it just needs to be more
relaxed and flowy. It would obviously relax you a bit and make you
calmer rather than a scary formal voice" (Female aged 15).
The utility of the audio-prompt was felt to be greater for new or
inexperienced AAI users, competent and confident users expressing
minimal utility for them: "Well the speaking thing is good. Well ‘need-
able’ for someone who doesn’t know what they are doing, whereas
usually, and most probably, it will be me using it. So I will know what I
am doing anyway" (Female aged 17).
Indication of correct administration
Young people desired confirmation and reassurance that the device
had been administrated correctly and the adrenaline had been
delivered.
“I think it is good that there is a click (audible click on some
devices) because you know exactly it is done" (Female aged 14).
"This might sound a bit complicated but maybe if it (AAI) just made
a noise, in a way, just maybe even if it had a voice recording on it, just
to tell you whether it was in. Or if a light came on, or just like this little
click" (Male aged 14).
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Some young people considered the emergence of the needle guard
on some AAIs after triggering the device acted as visual confirmation
of adrenaline delivery: "The orange bit (needle guard) comes out, and
the orange bit extends even more so you know when it's like used"
(Female aged 14).
Safety features
Some concerns were raised over the safety and robustness of the
external casing of existing devices, as users recalled instances of
disintegration and potential accidents, for example: "It is in a tube and
the lids are easy to snap off those, and then it (AAI) falls out and then
there is like, a chance of it coming out and stabbing you" (Male aged
13).
The inclusion of a needle guard was recognized as feature to reduce
accidental injury, particularly to bystanders unfamiliar with the device:
"For the safety around it because if you are out and it happens you are
usually have other people around you and you just don't want anyone
to pick it up" (Female aged 14).
The needle guard was also seen to provide psychological safety,
minimizing the impact of needle phobia: "I think the needle guard is
really clever because I guess the needle is quite frightening for me. I am
not a fan of injections or stuff, so I think that is a clever thing that you
can't see it, because maybe it would panic you more about using it next
time" (Female aged 14).
Speed of administration
A simple device, with minimal number of steps between decision to
use and delivery was favored by many. Preferences for pull-off caps
were expressed as these were considered quicker than screw caps and
could therefore reduce the time to injection. "I prefer the one where
you just pop off the lid, in a way, rather than having to spend time
screwing" (Male aged 14).
However, others were reluctant to sacrifice safety for speed,
expressing preference for screw mechanisms: "Screw cap would be
best, no risk of it coming off, and as long as it's not one that has to be
screwed around loads, then it won't really slow us down" (Female aged
16).
Young people recognized the advantages of an AAI looking like a
medical device and labeled appropriately: “If you could write the word
adrenaline or something in big letters. Because people would recognize
that. People who don't know anything about it would still recognize
"Ok, so that is the thing they need"” (Female aged 17).
Visibility and identification
Aesthetics were discussed in respect to the AAI being visible and
distinct as a medical device. Many participants talked about their
preference for a brightly colored device, as one that would be easier to
locate, for example in a large bag, and may alert others that the AAI is
a medical device to be used in an emergency: "I want to make it quite
bright so easy, easy to find wherever you are, but I don’t think there's a
particular color that would be good for me" (Female aged 14).
"You have got to have it in emergency colors to make it clear that it
is something for an emergency" (Female aged 17).
The expressed need for visibility was often accompanied by a desire
for the AAI to be “discreet” (Female aged 13).
Young females, having discussed brightly colored devices, often then
went on to discuss a need for an AAI to be discreet, enabling them to
‘blend in’ with the crowd or not to appear obviously untrusting of their
hosts’ ability to provide an allergen free meal: “It looks like a pen. So
people wouldn't ask as many questions. So it would be disguised
wouldn't it, so it would be just like in your bag and people wouldn't
really question it" (Female aged 15).
"It is good for it to have bright colors so that it stands out, in case I
was in a public place and somebody needed to find it, or if my friends
needed to find it. But then again it’s not the nicest thing to have a
bright yellow object just sitting in your bag." (Female aged 17)
"It seems a bit, if you are going around to a friend's house; it is a bit
untrusting if you have got it there. If they just see that I have got an
EpiPen in my bag, it doesn’t seem very polite almost." (Female aged 14)
Precise drug delivery
The availability of several AAI devices for participants to examine
prompted some discussion about the two types of injecting
mechanisms used; the “swing and push” and the “hold and press”
technique. Participants favored placing the injector on the skin and
then pressing; this was perceived to have greater accuracy for the
positioning of the injection, as well as causing less pain and not being
such a disconcerting action: "I think it's good that you just press in
instead of um swinging it because I think swinging it, it could go more
wrong, or you could do it too hard, or something. So I think it is clever
because you just press it down and I think that is easier as well"
(Female aged 14).
“The thought of having to swing something and stab it into you is
quite scary. So just having to press something is much better and less
frightful" (Female aged 13).
"I think a lot of people are worried about the big swing, like that
would hurt, whereas if you jab it in, you don't have to use loads of
force" (Female aged 14).
Some suggested the ability to deliver the injection to the appropriate
part of the thigh was more likely if changes were made to the shape
and grip of the device: "A round shape is easier to hold than a flat one"
(Male aged 16).
"Maybe it could have a bit more grip because in case you don't want
it to slide out of your fingers when you are doing it, because you are
quite nervous and everything. So you don't want to cut yourself or
something with it" (Female aged 14).
Additional design features
Some participants talked about the desirability for a device that was
able to deliver multiple doses should an error be made whilst
administering the first dose or where access to emergency services was
delayed. "I think that would be useful because at the moment I have to
carry around two of those, which is quite big" (Female aged 14).
“If the ambulance wasn't, if it didn't come quickly, so you could
inject you again" (Female aged 15).
Whilst convenience and compactness of a multiple-dose device was
desired this was sometimes accompanied by a fear that it might be
more complex to use, and if so this could outweigh the advantages: "I
think it is a good idea having another one, but I think it would be
much easier to just to have two simple (devices)" (Male aged 14).
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Discussion
Young people articulated readily their ideas about existing and
potential AAI devices, each talking for at least 30 minutes. The seven
major themes covered AAI carriage through to utilization and
disposal. In particular, there was a desire for design features to improve
portability and safety. When reflecting on design features, these young
people were alert to both their needs and the needs of others helping
them in an emergency. They were attentive to the need for clearer
instructions on AAIs generally, instructions that were readily available
and accessible to those with reading or linguistic difficulties. The need
for such design features are supported by data; in England 16% of
adults are functionally illiterate [17] and the prevalence of
unintentional injections of AAIs between 1994 and 2007 reported to
the American Association of Poison Control Centers was over 15,000
[18]. The implications of unintentional injection are two fold, the loss
of the medication dose needed by the anaphylactic patient and the
resulting discomfort and risk for the caregiver or bystander
accidentally injected [19,20]. These issues were raised more frequently
by older participants; perhaps reflecting the greater proportion of time
this age group spends away from parents and the increasing need to be
dependent on bystanders.
Whilst there was not a consensus on how AAIs should be improved,
there were frequent suggestions. This is perhaps most apparent when
discussing size of the device and its impact on carriage. There was
conflict between the AAI characteristics that facilitate discreet and easy
portability on a daily basis, (small AAI with unobtrusive coloring) and
the characteristics needed in a rare anaphylactic emergency where
prompt administration called for bold coloration and sufficient size to
aid easy location. Interestingly young people commented on the
disadvantage of changes to AAI design as people were familiar with the
somewhat undesirable, existing devices. The importance of device
familiarity is probably over-rated given that study after study has
demonstrated that patients’, careers’ and health professionals’ are
unfamiliar with the administration of even the most commonly
prescribed AAIs [21]. There is very little evidence to suggest that the
threatened loss of ‘familiarity’ with existing devices should ever be
used as an excuse to impede the development of better AAIs.
The desire to make their AAI less noticeable reflects the stigma of
being allergic and the need to fit in as a young person. Many young
people are teased about their allergies; this was found to be as high as
62% in a study of 174 American young people and young adults [10]
and 15% of children in the UK prescribed an AAI reported being
bullied [22]. There is an inherent tension in young people’s desires to
carry a device which is discreet and inconspicuous and yet
immediately identifiable in an emergency situation. Whether this
tension could be entirely resolved is doubtful but it is important to
consider how users’ anxieties relating to peer stigma and aesthetics can
be balanced with the need for the prompt identification of AAIs in an
emergency setting.
This research complements a previous study which focused only on
robustness and performance qualities of AAIs [23]. Our research adds
to an existing review of design focusing only on the pharmacokinetics
and ballistics of AAIs from a professional perspective [24].
Interestingly there are similarities between prescribers and users with
respect to pharmacological and clinical matters; the need for a device
which is simple and quick to administer in high stress situations, is
easy to carry and access, one that involves minimal steps to
administration and is safe were reported by professionals and also by
the young people in our study [24,25]. Human factors engineering, the
design of systems which conform to human capabilities and limitations
[26], has suggested that current AAIs are poorly designed, with some
models based on a metaphor (a pen), but not operated consistently
with that metaphor, leading to confusion during administration [27].
Involving users in the design phase of medicinal products is crucial;
research has demonstrated that testing a product on as few as four or
five users enables manufacturers to discover 80% of a product’s
usability problems [28].
This is a novel study exploring young persons’ experience of the
carriage and use of AAIs, the qualitative approach allowed for in-depth
understanding of perceptions and opinions that would be difficult to
capture in a survey or questionnaire. Our participants were recruited
from a single geographical area; however the issues raised are likely to
be generalizable to all AAI users, as they relate to matters independent
of the health care system. We recruited young people with varying
degrees of experience of AAI administration, and different
prescriptions of AAIs. One may argue that as many participants had
not previously used an AAI, they are unable to comment on design
when in fact we would argue that an unappealing design affects
adherence to carriage and impedes use which has been observed in
adults with allergy [29]. We did not record data on ethnicity but as the
geographical region is largely Caucasian, future work needs to explore
whether there are different cultural requirements. Our research
method was rigorous and analysis transparent, enabling the reader to
assess the transferability of our respondent comments to their locality.
After 23 respondents we had reached data saturation, whilst this is a
small sample size for quantitative studies, it is sufficient for qualitative
research where there was dense specificity, a narrow aim and strong
interview quality dialogue, all indicative of high information power
[30].
Young people can generate ideas for future AAI design which
improve their perceptions of the device and may facilitate their
carriage and use. AAI designers need to address these unmet
requirements with experience-based designs if we are to achieve
optimal self-management of severe allergy and anaphylaxis.
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